Home - Products - Angiogenesis - VEGFR - WAY-302159

WAY-302159

CAS No. 62802-77-1

WAY-302159( —— )

Catalog No. M29001 CAS No. 62802-77-1

WAY-302159 is a VEGFR2 inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	72	In Stock
10MG	125	In Stock
25MG	260	In Stock
50MG	410	In Stock
100MG	605	In Stock
500MG	1287	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

WAY-302159
Note

Research use only, not for human use.
Brief Description

WAY-302159 is a VEGFR2 inhibitor.
Description

WAY-302159 is a VEGFR2 inhibitor.(In Vitro):WAY-302159 Inhibited VEGF-induced proliferation in HUVEC cell.
In Vitro

VEGFR-2-IN-29 (Compound 5) (72 h) inhibits HUVEC proliferation. Cell Proliferation Assay Cell Line:HUVEC Concentration:Incubation Time: 72 h Result:Showed inhibition with IC50s of 15.8 nM and 210 nM against VEGF- and bFGF-induced HUVEC proliferation.
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

VEGFR
Recptor

VEGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

62802-77-1
Formula Weight

293.282
Molecular Formula

C16H11N3O3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 20 mg/mL (68.19 mM)
SMILES

[O-][N+](=O)c1cccc(c1)C(=O)Nc1cccc2cccnc12
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Motesanib

A potent, orally bioavailable, multikinase inhibitor inhibitor of VEGFR1/2/3, PDGFR and c-Kit with IC50 of 2-6 nM, 84 nM and 8 nM, respectively.
GSK269962A

GSK269962 is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
Cediranib

A highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.

Sign In Join Free